688617 惠泰医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)24.59229.09320.21918.57727.354
总资产报酬率 ROA (%)19.64522.25216.89115.98319.270
投入资产回报率 ROIC (%)23.56227.32619.24217.49922.075

边际利润分析
销售毛利率 (%)72.69071.26671.20469.48970.355
营业利润率 (%)38.64836.38432.64726.85024.914
息税前利润/营业总收入 (%)38.14535.94232.27326.81325.325
净利润/营业总收入 (%)34.23731.64027.97323.51321.733

收益指标分析
经营活动净收益/利润总额(%)94.46189.58394.16481.42986.718
价值变动净收益/利润总额(%)2.2073.8795.33814.814-0.056
营业外收支净额/利润总额(%)-0.433-0.679-0.470-0.4281.459

偿债能力分析
流动比率 (X)4.2272.9863.7817.9843.201
速动比率 (X)3.0502.4282.9616.6311.874
资产负债率 (%)13.11823.74619.53811.02923.547
带息债务/全部投入资本 (%)1.1425.7414.1053.4839.721
股东权益/带息债务 (%)8,584.5651,622.8042,308.0372,744.078917.478
股东权益/负债合计 (%)649.295312.144405.440800.893332.088
利息保障倍数 (X)-113.525-182.126-145.934346.318603.103

营运能力分析
应收账款周转天数 (天)8.8409.66112.01416.88434.083
存货周转天数 (天)238.993252.775309.035290.825364.881